Tuesday, December 27, 2016

The dawn of mRNA-based therapeutics for brain diseases

The dawn of mRNA-based therapeutics for brain diseases:

Dementia Big
The progressive dementia suffered by patients with Alzheimer’s disease (AD) affects millions of people globally each year and puts considerable strain on healthcare services. The mechanisms behind AD are not yet clear, and there are no effective therapies available to fully tackle the disease.


http://ift.tt/2izBIyw

No comments:

Post a Comment